FDA NDC Directory · JSON-LD · Markdown
NDC 59651-262 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA212923 |
| Dosage form / route | TABLET, ORALLY DISINTEGRATING · ORAL |
| Active ingredients | CLOZAPINE (100 mg/1) |
| Marketing started | 20241212 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).